Patent Assignment
Reel/Frame 024180/0767
Assignment of Assignor's Interest
Recorded: 2010-04-02
Pages: 3
Assignors
LEVEILLARD, THIERRY
Executed: 2003-10-13
SAHEL, JOSE ALAIN
Executed: 2003-10-11
MOHAND-SAID, SADDEK
Executed: 2003-10-13
HICKS, DAVID
Executed: 2003-10-03
Assignees
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
UNIVERSITE LOUIS PASTEUR
4, RUE BLAISE PASCAL, STRASBOURG, 67000, FRANCE
Covered Properties
(3)
Rod-Derived Cone Viability Factor (Rdcvf) and a Method of Enhancing Cone Cell Survival by Rdcvf
Polynucleotides Encoding Rod-Derived Cone Viability Factor (Rdcvf) and Methods of Using the Same
Retinal Dystrophy- Associated Protein and Uses Thereof
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 31, 2008
From: LEVEILLARD, THIERRY; SAHEL, JOSE ALAIN; MOHAND-SAID, SADDEK; HICKS, DAVID
To: NOVARTIS AG
Reel/Frame 020445/0095 →
Change of Name
Apr 2, 2010
From: UNIVERSITE LOUIS PASTEUR
To: UNIVERSITE DE STRASBOURG
Reel/Frame 024180/0795 →
Security Agreement
Aug 15, 2013
From: WELLSTAT OPHTHALMICS CORPORATION
To: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 031030/0720 →
Security Agreement
Sep 17, 2013
From: WELLSTAT OPHTHALMICS CORPORATION
To: PDL BIOPHARMA, INC.
Reel/Frame 031227/0182 →
Release of Security Interest
Jan 21, 2021
From: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
To: WELLSTAT OPHTHALMICS CORPORATION
Reel/Frame 054983/0577 →